Moreover, next-generation sequencing revealed that beyond BRCA1/2, mutations in homologous recombination effectors, such as PALB2, RAD51, ATM, BRIP1, BARD1, and CHEK2 also occur in breast cancer [12]. Here, ATM is linked to breast carcinoma.